The U.S. Food and Drug Administration (FDA) has updated its enforcement registers and safety alerts for the companion animal sector. Independent audit pipelines and voluntary company actions have flagged two major pet food brands, identifying risks ranging from severe neurological deficiencies to unannounced packaging mislabeling.
Pet owners, veterinary clinics, and retailers are urged to review inventory lists against these active safety directives.
1. QUEST Cat Food (GO RAW LLC): Expanded recall and nationwide Stop-Sale
Go Raw LLC (Cottonwood Heights, UT) has significantly expanded its voluntary recall of select Quest Cat Food Chicken Recipe products. Following initial warnings, the company has enacted a total nationwide stop-sale on all Quest product lines across all retail locations while it conducts an internal investigation into raw ingredient suppliers, formulation adjustments, and processing specifications.
The Core Biological Risk: Thiamine (Vitamin B1) Deficiency
Thiamine is an essential water-soluble vitamin required by felines for optimal carbohydrate metabolism and cellular energy production. Because cats cannot synthesize Vitamin B1 naturally, prolonged exposure to deficient commercial diets triggers a rapid, predictable biological breakdown across multiple organ systems.
Veterinarians classify the clinical progression of feline thiamine deficiency into two distinct diagnostic phases:
-
Early Gastrointestinal Markers: Initial indicators include a sudden decrease in appetite (anorexia), persistent salivation, unexpected vomiting, and progressive weight loss
-
Advanced Neurological System Crash: Left untreated, cats will experience dangerous neurological damage. Key symptoms include ventroflexion (an involuntary bending of the neck down toward the floor), severe mental dullness, vision impairment, wobbly walking (ataxia), circling, falling, and grand mal seizures
2. Farmina Pet Foods: Unannounced CLASS III Discovery via enforcement audits
A comprehensive analysis of the FDA Enforcement Reports database revealed a major, unannounced recall initiated by Farmina Pet Foods. The company recalled more than 8,000 bags of its premium ancestral-grain formulation.
Farmina N&D Tropical Selection
-
The Affected Product: Farmina N&D Tropical Selection – Salmon, Spelt, Oats and Tropical Fruits Recipe Adult Medium & Maxi Dog Food (Packaged in 22-pound commercial bags)
-
The Root Cause: Mislabeled Product Matrices. Internal auditing confirmed a stark error on the retail packaging: the front display panel prominently advertised a premium Salmon-based protein recipe, whereas the detailed ingredient panel on the back listed Lamb as the actual baseline protein source
-
Understanding the Regulatory Status: Class III (Low Risk)
The FDA has officially categorized this action as a Class III Recall. Under federal definitions, a Class III status is applied when a product violation is purely administrative or technical, meaning it is highly unlikely to cause adverse health consequences or illness in target animals.
Because Class III actions do not present immediate medical risks, manufacturers are not legally mandated to issue a public media press release. This explains why the recall proceeded unannounced through standard consumer channels and was only brought to light via direct federal enforcement logging.
Summary: Active May 2026 FDA Pet Food Recalls
Brand / Product Line
Primary Biological Risk
FDA Classification
Distribution Horizon
Mandatory Action Required
Quest Chicken (Go Raw LLC)
Critical Thiamine Deficiency; causes severe neurological seizures.
Voluntary Expansion & Total Stop-Sale
Nationwide Retail Network
Immediate Stop-Feed; return to local retailer for full refund.
Farmina N&D Tropical Selection
Ingredient Panel Mismatch (Front says Salmon; Back lists Lamb).
Class III (Low Risk / Unannounced)
8,000+ Premium 22lb Bags
Verify ingredient list; cross-check for
